This NDC is on FDA's drug shortage list (posted Oct 12, 2022)
Product Information
DEXTROAMP-AMPHETAMIN 20 MG TAB is a generic product labeled by SpecGx LLC, priced at $0.2946 per EA under NDC 00406889301. Its NADAC has been published 616 times since Mar 12, 2014.
FDA first approved this application on Oct 7, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHETAMIN 20 MG TAB
Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine SulfateStrength
5; 5; 5; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
SpecGx LLCNDC
00406889301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA040440FDA Approved
10/7/2003
TE Code
AB
On Market Since
10/7/2003
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has been published 616 times since Mar 12, 2014, and over the history we have for it it has declined 68.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2946 per EA |
|---|---|
| All-time high | $0.9574 (Apr 16, 2014) |
| All-time low | $0.2545 (Apr 17, 2024) |
| 52-week high | $0.3361 |
| 52-week low | $0.2946 |
| Median price | $0.3815 |
| Average price | $0.4423 |
| Largest weekly change | +26.2% (Jun 19, 2024) |
| Weeks tracked | 616 |
| Tracking since | Mar 12, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAMIN 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 20 MG TAB, manufactured by SpecGx LLC, is $0.2946 per EA (NDC 00406889301), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAMIN 20 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has declined 68.7%. It has been tracked across 616 weekly CMS publications since Mar 12, 2014.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 20 MG TAB?
Since Mar 12, 2014, the NADAC for DEXTROAMP-AMPHETAMIN 20 MG TAB has ranged from a low of $0.2545 (Apr 17, 2024) to a high of $0.9574 (Apr 16, 2014), with a median of $0.3815 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 20 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAMIN 20 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAMIN 20 MG TAB?
DEXTROAMP-AMPHETAMIN 20 MG TAB (NDC 00406889301) is labeled by SpecGx LLC, and CMS classifies it as a generic product.
Is DEXTROAMP-AMPHETAMIN 20 MG TAB in shortage?
Yes — NDC 00406889301 is currently listed in FDA's drug shortage database (posted Oct 12, 2022).